The Board of directors of Jenburkt Pharmaceuticals Limited at its meeting held on 23rd May, 2023, have approved / recommended a dividend of Rs. 14.40 i.e., 144% per equity share of Rs. 10/- each.
New Delhi [India], April 2 (ANI/Target Media): Jenburkt Wellness, the premium consumer-wellness division from the house of publicly listed organization Jenburkt Pharmaceuticals Ltd, announced the launch of Zixa Strong, a high-performing pain-relief range that delivers fast-acting and long-lasting relief from muscle and joint pains